19 May 2022
Mpac Group plc
("Mpac" or the "Company")
EBT Subscription & Total Voting Rights
Mpac, a global leader in high-speed packaging and automation solutions, announces that the Company's Employee Benefit Trust has subscribed for 220,276 ordinary shares of 25 pence each in the Company ("Ordinary Shares") at par value (the "EBT Subscription"). The EBT Subscription will be used to satisfy vesting of awards under the Company's Long-Term Incentive Plan. The Company has agreed to loan the EBT £55,069 to pay for the EBT Subscription.
Application has been made to the London Stock Exchange for the 220,276 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 24 May 2022. The Ordinary Shares will be issued fully paid and will, upon issue, rank pari passu in all respects with the Company's existing Ordinary Shares.
Total Voting Rights
Following Admission, the Company will have 20,391,816 Ordinary Shares in issue, with voting rights attached. Of these, no Ordinary Shares are held exclusive of voting rights in treasury. Therefore the total number of voting rights in the Company will be 20,391,816 and shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company.
For further information, please contact:
| Mpac Group plc Tony Steels, Chief Executive Will Wilkins, Group Finance Director
| Tel: +44(0)24 7642 1100 |
| Shore Capital (Nominated Adviser & Broker) Advisory Patrick Castle Iain Sexton Broking Henry Willcocks
| Tel: +44(0)20 7408 4050
|
| Hudson Sandler Nick Lyon / Nick Moore | Tel: +44(0)20 7796 4133 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.